Johns Hopkins HIV Guide
Fosamprenavir
INDICATIONS
FDA
FDA
- Treatment of HIV-1 infection in combination with other antiretroviral agents.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 6, 2026
Citation
Soto, Caitlin, and Paul G Auwaerter. "Fosamprenavir." Johns Hopkins HIV Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545076/9/Fosamprenavir.
Soto C, Auwaerter PG. Fosamprenavir. Johns Hopkins HIV Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545076/9/Fosamprenavir. Accessed September 17, 2026.
Soto, C., & Auwaerter, P. G. (2026). Fosamprenavir. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545076/9/Fosamprenavir
Soto C, Auwaerter PG. Fosamprenavir [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2026. [cited 2026 September 17]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545076/9/Fosamprenavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fosamprenavir
ID - 545076
A1 - Soto,Caitlin,PharmD, BCIDP
AU - Auwaerter,Paul,M.D.
Y1 - 2026/09/06/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545076/9/Fosamprenavir
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
